ALBION FINANCIAL GROUP /UT - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 107 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 5.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALBION FINANCIAL GROUP /UT ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q1 2023$1,488
-0.8%
2,1250.0%0.00%
Q4 2022$1,500
-50.0%
2,1250.0%0.00%
Q3 2022$3,000
+50.0%
2,1250.0%0.00%
Q2 2022$2,000
-33.3%
2,1250.0%0.00%
Q1 2022$3,000
-72.7%
2,1250.0%0.00%
-100.0%
Q4 2021$11,000
-8.3%
2,1250.0%0.00%0.0%
Q3 2021$12,000
-29.4%
2,1250.0%0.00%0.0%
Q2 2021$17,000
+6.2%
2,1250.0%0.00%
-50.0%
Q4 2020$16,000
-92.1%
2,125
-80.4%
0.00%
-92.3%
Q3 2019$202,000
-18.5%
10,8580.0%0.03%
-18.8%
Q2 2019$248,000
+8.8%
10,8580.0%0.03%
+3.2%
Q1 2019$228,000
+7.5%
10,858
-41.0%
0.03%
-6.1%
Q4 2018$212,000
-67.8%
18,408
-35.8%
0.03%
-62.9%
Q3 2018$658,000
-16.0%
28,658
-18.4%
0.09%
-21.2%
Q2 2018$783,000
-68.1%
35,108
-67.4%
0.11%
-40.2%
Q1 2018$2,458,000
+64.6%
107,556
+88.8%
0.19%
-16.7%
Q4 2017$1,493,000
+14.1%
56,978
-2.2%
0.23%
+13.5%
Q3 2017$1,308,000
-17.9%
58,2780.0%0.20%
-24.5%
Q2 2017$1,594,000
+13.0%
58,2780.0%0.26%
+25.0%
Q1 2017$1,410,000
-9.4%
58,278
-22.3%
0.21%
-17.5%
Q4 2016$1,556,000
-19.0%
74,978
+6.4%
0.26%
-21.9%
Q3 2016$1,921,000
+89.3%
70,478
-0.1%
0.33%
+80.8%
Q2 2016$1,015,000
+0.1%
70,543
-0.1%
0.18%
+5.8%
Q1 2016$1,014,000
-25.2%
70,593
+11.9%
0.17%
-26.2%
Q4 2015$1,356,000
+53.2%
63,093
+15.4%
0.23%
+45.6%
Q3 2015$885,000
-26.6%
54,693
+17.1%
0.16%
-20.0%
Q2 2015$1,205,000
+7.8%
46,693
-6.0%
0.20%
+5.3%
Q1 2015$1,118,000
+2.8%
49,693
-12.4%
0.19%
+1.1%
Q4 2014$1,088,000
-10.7%
56,709
-0.0%
0.19%
-13.0%
Q3 2014$1,218,000
+6.1%
56,723
+28.4%
0.22%
+8.5%
Q2 2014$1,148,000
+22.1%
44,171
+2.4%
0.20%
+15.0%
Q1 2014$940,000
+74.7%
43,120
-2.3%
0.17%
+71.3%
Q4 2013$538,000
-21.0%
44,120
-13.2%
0.10%
-30.3%
Q3 2013$681,000
+64.9%
50,8200.0%0.14%
+57.6%
Q2 2013$413,00050,8200.09%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders